Ago

Ago is an Austria-based medical device startup focused on cardiovascular surgery, specifically devices used during surgical replacement of the ascending aorta. The company is reported to be developing the Aortic Graft Occluder, a device intended for intraoperative testing of a tubular aortic graft attached to the aortic root and for checking aortic valve function and blood leakages. Available public information suggests Ago is an early-stage, privately held medtech company rather than a therapeutic biotech or pharma developer. Its profile indicates the company was founded in 2021 in Wiener Neustadt, Austria, and has received institutional backing from NLC. Publicly available pipeline and corporate details remain limited.